In the past week, HOLX stock has gone down by -4.89%, with a monthly decline of -7.04% and a quarterly plunge of -10.58%. The volatility ratio for the week is 3.44%, and the volatility levels for the last 30 days are 2.03% for Hologic, Inc The simple moving average for the past 20 days is -5.05% for HOLX’s stock, with a -6.09% simple moving average for the past 200 days.
Is It Worth Investing in Hologic, Inc (NASDAQ: HOLX) Right Now?
The price-to-earnings ratio for Hologic, Inc (NASDAQ: HOLX) is above average at 22.00x. The 36-month beta value for HOLX is also noteworthy at 0.97. There are mixed opinions on the stock, with 5 analysts rating it as a “buy,” 5 rating it as “overweight,” 10 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for HOLX is 223.70M, and at present, short sellers hold a 2.75% of that float. The average trading volume of HOLX on December 17, 2024 was 1.69M shares.
HOLX) stock’s latest price update
Hologic, Inc (NASDAQ: HOLX) has seen a rise in its stock price by 0.87 in relation to its previous close of 72.44. However, the company has experienced a -4.89% decline in its stock price over the last five trading sessions. zacks.com reported 2024-12-13 that Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock’s prospects.
Analysts’ Opinion of HOLX
Needham, on the other hand, stated in their research note that they expect to see HOLX reach a price target of $90. The rating they have provided for HOLX stocks is “Buy” according to the report published on December 10th, 2024.
Jefferies gave a rating of “Hold” to HOLX, setting the target price at $85 in the report published on December 10th of the current year.
HOLX Trading at -7.56% from the 50-Day Moving Average
After a stumble in the market that brought HOLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -13.70% of loss for the given period.
Volatility was left at 2.03%, however, over the last 30 days, the volatility rate increased by 3.44%, as shares sank -6.82% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -8.09% lower at present.
During the last 5 trading sessions, HOLX fell by -4.44%, which changed the moving average for the period of 200-days by -1.58% in comparison to the 20-day moving average, which settled at $76.97. In addition, Hologic, Inc saw 2.27% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HOLX starting from Mitchell Essex D, who sale 24,856 shares at the price of $76.34 back on Dec 04 ’24. After this action, Mitchell Essex D now owns 27,957 shares of Hologic, Inc, valued at $1,897,482 using the latest closing price.
Mitchell Essex D, the Officer of Hologic, Inc, proposed sale 24,856 shares at $76.34 during a trade that took place back on Dec 04 ’24, which means that Mitchell Essex D is holding shares at $1,897,484 based on the most recent closing price.
Stock Fundamentals for HOLX
Current profitability levels for the company are sitting at:
- 0.23 for the present operating margin
- 0.56 for the gross margin
The net margin for Hologic, Inc stands at 0.2. The total capital return value is set at 0.12. Equity return is now at value 15.56, with 8.63 for asset returns.
Based on Hologic, Inc (HOLX), the company’s capital structure generated 0.33 points at debt to capital in total, while cash flow to debt ratio is standing at 0.51. The debt to equity ratio resting at 0.49. The interest coverage ratio of the stock is 7.66.
Currently, EBITDA for the company is 1.3 billion with net debt to EBITDA at 0.29. When we switch over and look at the enterprise to sales, we see a ratio of 4.2. The receivables turnover for the company is 6.71for trailing twelve months and the total asset turnover is 0.44. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.69.
Conclusion
In summary, Hologic, Inc (HOLX) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
